Related Experiment Video

Updated: Jul 17, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Hypercholesterolaemia impairs monocyte function in CAD patients

F S Czepluch1, A Bergler, J Waltenberger

  • 1Department of Cardiology, University of Maastricht, Maastricht, the Netherlands.

Journal of Internal Medicine
|January 24, 2007
PubMed

Insights

High cholesterol impairs monocyte function, hindering collateral artery growth in patients with coronary artery disease. This dysfunction is linked to the severity of hypercholesterolaemia and may be reversible with statins.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Cell Biology

Background:

  • Hypercholesterolaemia (HC) is a significant cardiovascular risk factor.
  • Impaired arteriogenesis (collateral artery growth) is a consequence of HC.
  • Monocytes play a critical role in mediating arteriogenesis.

Purpose of the Study:

  • To investigate the impact of HC on monocyte chemotaxis.
  • To assess monocyte response to arteriogenic ligands vascular endothelial growth factor-A (VEGF-A) and monocyte chemoattractant protein-1 (MCP-1).

Main Methods:

  • Monocyte migration assays were performed using cells from hypercholesterolaemic coronary artery disease (CAD) patients, hypercholesterolaemic controls, and healthy controls.
  • VEGF-A and MCP-1 were used as chemoattractants.
  • Serum VEGF-A levels were measured in all participants.

Main Results:

  • Monocyte chemotaxis towards VEGF-A and MCP-1 was significantly impaired in hypercholesterolaemic CAD patients compared to healthy controls.
  • Hypercholesterolaemic controls also showed reduced monocyte chemotaxis, but to a lesser extent than CAD patients.
  • No significant difference in serum VEGF-A levels was observed between the groups.

Conclusions:

  • Hypercholesterolaemia severely impairs monocyte function in CAD patients, likely contributing to reduced collateral artery growth.
  • The duration of hypercholesterolaemia may influence the degree of monocyte dysfunction.
  • Further research is needed to explore statin therapy's potential to reverse these effects.
Abstract

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview